Loading...
Back to narrative

Update shared on27 Aug 2025

Fair value Increased 2.74%
AnalystConsensusTarget's Fair Value
US$22.84
20.6% undervalued intrinsic discount
27 Aug
US$18.14
Loading
1Y
-1.5%
7D
10.2%

Analysts have modestly raised XP's price target to $22.84 as bullish sentiment around improved fundamentals offsets bearish concerns over limited upside and competitive challenges.


Analyst Commentary


  • Bearish analysts cite concerns over limited upside to justify a downgrade and reduced price target.
  • Bullish analysts note improved fundamentals and recent business performance as reasons for a higher price target.
  • Revisions reflect changing expectations of XP's growth trajectory in a competitive environment.
  • Analysts are incorporating an updated macroeconomic outlook into their valuation models.
  • The disparity in targets highlights diverging views on XP’s ability to execute strategic initiatives going forward.

What's in the News


  • XP Inc. held a board meeting to review and approve its unaudited interim condensed consolidated financial statements as of June 30, 2025.

Valuation Changes


Summary of Valuation Changes for XP

  • The Consensus Analyst Price Target has risen slightly from $22.23 to $22.84.
  • The Future P/E for XP has significantly fallen from 12.72x to 2.36x.
  • The Consensus Revenue Growth forecasts for XP has fallen from 15.3% per annum to 14.5% per annum.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.